Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 14, 2021

View Archived Issues

Pre-existing chromosomal instability may predict response to paclitaxel

ORAI1 behind the pathogenesis of pulmonary arterial hypertension

C-118P demonstrates antiproliferative activity in models of HCC

ARN-75039 or ARN-75041 as potent arenavirus fusion inhibitors

ASCT2 is a prognostic marker in renal cell carcinoma

Twist Bioscience and Adicet collaborate on discovery of gamma delta T-cell cancer therapies

OncoPLEX yields promising results in animal models of GBM

Repurposing ritonavir as potential disease-modifying therapy for dystonia

USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection

Discovery of apigenin derivative with potential to overcome drug-resistant MET-mutant RCC

PearlRiverBio patents EGFR and HER2 mutant inhibitors

Tempest Therapeutics licenses intellectual property to cancer target from University of California

Beta Pharma presents new GTPase KRAS mutant inhibitors

vTv Therapeutics discloses glucokinase activators

SQZ announces celiac disease as first autoimmune clinical translation of TAC platform

Strong nectin-4 expression tied to poor prognosis in UTUC

Satellos reports preclinical data on drug candidate in mouse model of DMD

Kinnate presents preclinical data on next-generation pan-FGFR inhibitor KIN-3248

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...